Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. by Prevo, R, Deutsch, E, Sampson, O, Diplexcito, J, Cengel, K, Harper, J, O'Neill, P, Mckenna, W, Patel, S, Bernhard, E